Showing 4481-4490 of 5627 results for "".
- SIFI Receives Marketing Authorization for Ophthalmic Products in in Turkeyhttps://modernod.com/news/sifi-recevies-marketing-authorizations-for-ophthalmic-products-in-in-turkey/2478996/SIFI, has announced that the Turkish Medicines and Medical Devices Agency (TMMDA) has approved the transfer of marketing authorizations from its former local distributor to its wholly owned subsidiary SIFI İlaç A.S. The approvals cover different formulations of ophthalmic drugs Netira, Netildex,
- Senate Narrowly Confirms Becerra as HHS Secretaryhttps://modernod.com/news/senate-narrowly-confirms-becerra-as-hhs-secretary/2478991/The Senate has narrowly confirmed California Attorney General Xavier Becerra as secretary of the Department of Health and Human Services, according to a FierceHealthcare
- EMA’s Blood Clot Review Exonerates AstraZeneca COVID-19 Vaccine, But Monitoring Continueshttps://modernod.com/news/emas-blood-clot-review-exonerates-astrazeneca-covid-19-vaccine-but-monitoring-continues/2478990/The European Medicines Agency (EMA) on Thursday said a review by its Pharmacovigilance Risk Assessment Committee (PRAC) has determined that AstraZeneca’s COVID-19 vaccine AZD1222 is safe and effective at preventing COVID-19, and that its benefits are “far greater” than any poten
- BJO Publishes New Data on Clearside Biomedical’s Investigational Treatment Xiperehttps://modernod.com/news/bjo-publishes-new-data-on-clearside-biomedicals-investigational-treatment-xipere/2478989/New data has been published in The British Journal of Ophthalmology related to the clinical development program of Clearside Biomedical’s Xipere, an investigational treatment with a proposed indication of macular edema associated with noninfectious uveitis.
- Rabb-Venable Excellence in Ophthalmology Program Abstract Submission Open Until March 31https://modernod.com/news/rabb-venable-excellence-in-ophthalmology-program-abstract-submission-open-until-march-31/2478981/Each year, the National Medical Association–Ophthalmology Section sponsors the Rabb-Venable Excellence in Ophthalmology Program, which is committed to increasing diversity in eye care to better reflect the U.S. population. The Rabb-Venable Program encourages and fosters interest in ophthal
- J&J’s Coronavirus Vaccine Garners WHO Emergency-Use Listinghttps://modernod.com/news/jjs-coronavirus-vaccine-garners-who-emergency-use-listing/2478968/Johnson & Johnson said that the World Health Organization (WHO) has issued an emergency-use listing for its single-dose coronavirus vaccine Ad26.COV2.S to prevent COVID-19 in people 18 years and older. Chief scientific officer Paul Stoffels stated that “achieving this important prerequi
- NIH-Led Team Sets New Bar in Retinal Imaginghttps://modernod.com/news/nih-led-team-sets-new-bar-in-retinal-imaging/2478963/A team led by scientists at the National Eye Institute (NEI) has noninvasively visualized the light-sensing cells in the back of the eye, known as photoreceptors, in greater detail than ever before. Published in Optica, the researchers report how they improved imaging resolution by a thi
- ASCRS Introduces Richard L. Lindstrom Lecture for 2021 Annual Meetinghttps://modernod.com/news/ascrs-introduces-richard-l-lindstrom-lecture-for-2021-annual-meeting/2478960/The American Society of Cataract and Refractive Surgery (ASCRS) has announced the inaugural Richard L. Lindstrom Lecture and Medal, which will be delivered along with other distinguished lectures at the 2021 ASCRS Annual Meeting in Las Vegas, Nevada. The Richard L. Lindstrom Lecture and Me
- New Study Links Protein Causing Alzheimer’s Disease With Common Sight Losshttps://modernod.com/news/new-study-links-protein-causing-alzheimers-disease-with-common-sight-loss/2478957/Newly published research has revealed a close link between proteins associated with Alzheimer’s disease and age-related sight loss. The findings could open the way to new treatments for patients with deteriorating vision and through this study, scientists believe they could reduce the need for us
- Samsara Vision and Medevise Consulting Announce European Partnershiphttps://modernod.com/news/samsara-vision-and-medevise-consulting-announce-european-partnership/2478956/Samsara Vision announced it will partner with Medevise Consulting to build a dedicated commercial organization to support Samsara Vision’s Tsert SI Implantable Miniature Telescope (IMT) (by Isaac Lipshitz). The two companies will collaborate to advance clinical research, coordinate reimbursement,